Login
Home / 600645.SS : SHH
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Vcanbio Cell & Gene Engineering Corp., Ltd

¥17.83 -$8.91 (-33.32%)
SHH · 15 Sep 2026 07:00 UTC
Previous Close
¥18.06
Day Range
¥17.8¥18.11
Year Range
¥16.24¥32.99
Market Cap
8.11B
AVG Volume
11.98M
Trailing/Forward PE
70.39/45.72
PEG ratio
4.79
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Shanghai Stock ExchangeCN
Revenue (CNY)
0200M400M600M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Net Income (CNY)
-50M-25M025M50M75M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Operating Income (CNY)
-50M050M100M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EBITDA (CNY)
050M100M150M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash Flows (CNY)
025M50M75M100M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EPS (CNY)
-0.1-0.0500.050.10.1524 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Expenses (CNY)
0100M200M300MR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash & Debt (CNY)
0500M1B1.5B2BCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Debt ratios
-8-6-4-2024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Margins
0%20%40%60%80%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Return on Capital
-1%0%1%2%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Shares Outstanding
0200M400M600M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Dividends (CNY)
00.020.040.060.08Apr 95Jul 98Aug 01
Book Value Per Share (CNY)
02.557.51024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Total Assets (CNY)
02B4B6B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PE Ratio
50100150200med 103.11Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Free Cash Flow Yield
1.5%2%2.5%3%3.5%med 2.18%Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Price to Sales
46810med 6.82Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
EV/EBITDA
102030405060med 32.8Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Price/Operating Cashflow
202530354045med 35.74Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Price to Book
22.533.54med 2.87Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Vcanbio Cell & Gene Engineering Corp., Ltd
600645.SS
Stockpicker

Video analysis: 600645.SS

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.